<?xml version="1.0" encoding="ISO-8859-1"?>
<rss version="0.91">
  <channel>
    <title>Bionity.COM News</title>
    <description>The latest news about trends and developments in the biotech, pharma and life science industries</description>
    <link>http://www.bionity.com/news/e/</link>
    <language>en-us</language>
 
  <item>
      <title>Berkeley Researchers Identify Photosynthetic Dimmer Switch</title>
      <link>http://www.bionity.com/news/e/81962/?WT.mc_id=ca0068</link>
      <description>In a study of the molecular mechanisms by which plants protect themselves from oxidation damage should they absorb too much sunlight during photosynthesis, a team of researchers has discovered a ...</description>
    </item>
  <item>
      <title>Cytopia announces novel anti-cancer drug development collaboration</title>
      <link>http://www.bionity.com/news/e/81961/?WT.mc_id=ca0068</link>
      <description>Cytopia Limited announced that it has entered into an anti-cancer drug discovery and development collaboration with Cancer Therapeutics CRC Pty Ltd. This agreement leverages Cytopia's early stage ...</description>
    </item>
  <item>
      <title>FivePrime Reports Discovery of IL-34</title>
      <link>http://www.bionity.com/news/e/81957/?WT.mc_id=ca0068</link>
      <description>Science, researchers at Five Prime Therapeutics, Inc. report the discovery of Interleukin34, a novel cytokine, as well as the identification of an IL-34 receptor."This work is a textbook example of ...</description>
    </item>
  <item>
      <title>Quest PharmaTech Signs Agreement to sell Bionex Technology</title>
      <link>http://www.bionity.com/news/e/81964/?WT.mc_id=ca0068</link>
      <description>Quest PharmaTech Inc. announced that it has signed a Technology Transfer Agreement with Peking Marvel Cleansing Supplies Co., Ltd., a China-based company, to sell its interest in the Bionex ...</description>
    </item>
  <item>
      <title>KeyNeurotek Pharmaceuticals Reports Positive Phase I Data of Its Cannabinoid Receptor-Agonist</title>
      <link>http://www.bionity.com/news/e/81960/?WT.mc_id=ca0068</link>
      <description>KeyNeurotek Pharmaceuticals AG announced positive results of a Phase I study with its cannabinoid receptor-agonist KN38-7271. KN38-7271 is being developed for the treatment of patients suffering from ...</description>
    </item>
  <item>
      <title>Agilent Technologies Expands Therapeutic Nucleic Acids Manufacturing Capacity</title>
      <link>http://www.bionity.com/news/e/81893/?WT.mc_id=ca0068</link>
      <description>Agilent Technologies Inc. announced the expansion of its nucleic acid active pharmaceutical ingredient (API) manufacturing facility in Boulder, Colo. Agilent's Nucleic Acids Solutions Division is ...</description>
    </item>
  <item>
      <title>CRELUX and ProQinase establish joint crystal-grade kinase protein and structures platform</title>
      <link>http://www.bionity.com/news/e/81894/?WT.mc_id=ca0068</link>
      <description>CRELUX and ProQinase announced that they have entered into a joint agreement to supply customers with crystal-grade protein kinases and readily available kinase complex structures. Under the ...</description>
    </item>
  <item>
      <title>Microbix to spin off Urokinase into newly formed Klarogen Biotherapeutics</title>
      <link>http://www.bionity.com/news/e/81886/?WT.mc_id=ca0068</link>
      <description>Microbix Biosystems Inc. announced that it intends to spin off its Urokinase assets into a new private company, Klarogen Biotherapeutics Inc., which would become the sole commercial-scale ...</description>
    </item>
  <item>
      <title>Commission procrastinates on GMOs while millions of farmers worldwide are growing them</title>
      <link>http://www.bionity.com/news/e/81892/?WT.mc_id=ca0068</link>
      <description>The EU Commission held a debate on the biotech crop approval process in Europe and sent out a disappointing signal when it agreed to send back three cultivation dossiers which had been positively ...</description>
    </item>
  <item>
      <title>Platypus genome reveals evolutionary path that gave mammals reproductive edge</title>
      <link>http://www.bionity.com/news/e/81888/?WT.mc_id=ca0068</link>
      <description>The odd-looking platypus is often cited as proof that God has a sense of humor. Now researchers at the Stanford University School of Medicine have turned to the strange animal to understand the ...</description>
    </item>
  <item>
      <title>An award for young scientists in a young discipline</title>
      <link>http://www.bionity.com/news/e/81825/?WT.mc_id=ca0068</link>
      <description>Systems Biology is a young field. It has the potential to fundamentally change the life sciences and generate radically new insights for biomedical research as well as for industry and agriculture. ...</description>
    </item>
  <item>
      <title>Cornell researchers study bacterium big enough to see</title>
      <link>http://www.bionity.com/news/e/81870/?WT.mc_id=ca0068</link>
      <description>The secret to an unusual bacterium's massive size - it's the size of a grain of salt, or a million times bigger than E. coli bacteria, and big enough to see with the naked eye - may be found in its ...</description>
    </item>
  <item>
      <title>DIREVO announces validation of bestMab</title>
      <link>http://www.bionity.com/news/e/81874/?WT.mc_id=ca0068</link>
      <description>DIREVO Biotech AG announced that it has validated its "bestMab(TM)" platform through the generation of an optimized version of the anti-inflammatory antibody, Adalimumab (Humira®), with ...</description>
    </item>
  <item>
      <title>Medgenics appoints Vice President of Clinical Affairs</title>
      <link>http://www.bionity.com/news/e/81871/?WT.mc_id=ca0068</link>
      <description>Medgenics announced that it has appointed Dr. Ehud Shoshani, former CEO of Quintiles, Israel, as its Vice President of Clinical Affairs. Dr. Shoshani will manage the Company's Phase I/II clinical ...</description>
    </item>
  <item>
      <title>LC Sciences and DNAVision form Strategic Marketing Alliance</title>
      <link>http://www.bionity.com/news/e/81868/?WT.mc_id=ca0068</link>
      <description>LC Sciences announced that it has entered into a strategic marketing alliance with DNAVision to increase accessibility to its custom microRNA profiling service and enhance both its customer and ...</description>
    </item>
  <item>
      <title>Amylin Initiates Phase 2B Dose-Ranging Clinical Study of Pramlintide/Metreleptin Combination Treatment in Obesity</title>
      <link>http://www.bionity.com/news/e/81769/?WT.mc_id=ca0068</link>
      <description>Amylin Pharmaceuticals, Inc. announced the initiation of a Phase 2B clinical study evaluating various dosing combinations of pramlintide, an analog of the natural hormone amylin, and recombinant ...</description>
    </item>
  <item>
      <title>Galapagos and Allergan enter drug discovery collaboration</title>
      <link>http://www.bionity.com/news/e/81781/?WT.mc_id=ca0068</link>
      <description>Galapagos NV announced today that Galapagos' service division, BioFocus DPI, will provide hit-finding services for multiple Allergan, Inc. targets. Total contract value for Galapagos could reach up ...</description>
    </item>
  <item>
      <title>Genenews adds two members to its Board of Directors</title>
      <link>http://www.bionity.com/news/e/81765/?WT.mc_id=ca0068</link>
      <description>GeneNews Limited announced its shareholders recently elected two additional members to its Board of Directors, Mr. Harry A. Glorikian and Ms. Fran Tuttle. They join Mr. Rory Riggs, Mr. James ...</description>
    </item>
  <item>
      <title>NicOx announces U.S. phase 2a results for PF-03187207 and gives an update on continuing NO-prostaglandin program</title>
      <link>http://www.bionity.com/news/e/81776/?WT.mc_id=ca0068</link>
      <description>NicOx S.A. announced the results of a U.S. phase 2 study, conducted by its partner Pfizer Inc, which compared the safety and efficacy of various doses of PF-03187207 to Xalatan® (latanoprost) 0.005% ...</description>
    </item>
  <item>
      <title>Novartis Menveo vaccine shows superior immune response against four types of meningitis disease in pivotal phase III trial</title>
      <link>http://www.bionity.com/news/e/81767/?WT.mc_id=ca0068</link>
      <description>New Phase III data for Menveo® (MenACWY-CRM) show that the vaccine produced a greater immune response against meningococcal serogroups A, C, W-135 and Y in adolescents 11-18 years of age compared to ...</description>
    </item>
 
<copyright>© 2008, Chemie.DE Information Service GmbH.</copyright>
  </channel>
</rss>
